First-line treatment with cadonilimab plus paclitaxel-platinum ± bevacizumab for persistent, recurrent, or metastatic cervical cancer: a retrospective real-world study

Xin Wang & Xia He et al. · 2025

Links
Authors
Xin Wang, Chunsheng Wang, Dan Zong, Biqing Zhu, Xia He